Catalent Inc (CTLT)

Exchange
NYSE
Symbol
CTLT
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Catalent, Inc. (Catalent Pharma Solutions) is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products.
Country
USA

Stock price

At close: October 3, 2024

  • Open
    60.51
  • High
    60.71
  • Low
    60.39
  • Close
    60.71
  • Volume
    775,908

Financial ratios

Jun 30, 2024

Activity ratios
Inventory turnover
5.97
Receivables turnover
4.76
Payables turnover
9.50
Working capital turnover
2.80
Days of inventory on hand (DOH)
61.12
Days of sales outstanding (DSO)
76.73
Number of days of payables
38.44
Fixed asset turnover
1.20
Total asset turnover
0.45
 Liquidity ratios
Current ratio
2.52
Quick ratio
1.17
Cash ratio
0.28
Cash conversion cycle
99.41
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
2.71
Interest coverage
-32.57
 Profitability ratios
Gross profit margin
21.75%
Operating profit margin
-17.10%
Pretax margin
-23.44%
Net profit margin
-23.81%
Operating return on assets (Operating ROA)
-7.68%
Return on assets (ROA)
-10.69%
Return on total capital
-20.78%
Return on equity (ROE)
-28.94%